WuXi AppTec files complaint against US DoD for linking it to Chinese military

Chinese drug research and development firm WuXi AppTec has initiated legal proceedings against the United States Department of Defense. The company filed a complaint in the U.S. District Court for the District of Columbia on Thursday, challenging its inclusion on a list that links it to the Chinese military.

The lawsuit marks a significant escalation in the dispute between the company and the U.S. government. WuXi AppTec, a major player in the pharmaceutical supply chain, argues that the Department of Defense's designation is unwarranted and harmful to its business operations.

Details of the specific allegations within the complaint have not yet been fully disclosed, but the core of the legal challenge revolves around the DoD's assessment and subsequent listing of the company. WuXi AppTec aims to have this designation overturned through the court.

The U.S. government has been increasingly scrutinizing companies with ties to China, particularly those operating in sensitive sectors like biotechnology and defense. This case highlights the ongoing tensions and legal battles emerging from these geopolitical considerations.